LUKE EVNIN Insider Trading $SNDX Syndax Pharmaceuticals Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKE EVNIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKE EVNIN. LUKE EVNIN is in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Syndax Pharmaceuticals Inc ($SNDX) and in Radius Health, Inc. ($RDUS) and Director in Harpoon Therapeutics, Inc. ($HARP) and Director in Werewolf Therapeutics, Inc. ($HOWL) and Chief Executive Officer in TURMERIC ACQUISITION CORP. ($TMPM).
LUKE EVNIN in Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKE EVNIN:
Holdings: 2,168,691 shares
Current Value: $18,845,925
Latest Transaction: May 25 2018
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LUKE EVNIN in Syndax Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HARP, RDUS, RIGL, SNDX, TMPMU, HOWL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2018 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 8.93 | 14,000 | 125,020 | 14,000 | ||
| Feb 12 2018 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 9.63 | 10,000 | 96,300 | 10,000 | ||
| May 19 2017 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 13.58 | 5,000 | 67,900 | 5,000 | ||
| May 19 2017 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 13.58 | 10,000 | 135,800 | 10,000 | ||
| Nov 02 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Option Exercise | A | 11.81 | 8,000 | 94,480 | 8,000 | ||
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 312,085 | 0 | 0 | |
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 718,396 | 0 | 0 | |
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Option Exercise | C | 0.00 | 1,138,210 | 0 | 0 | |
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 312,085 | 0 | 2,168,691 | 1.9 M to 2.2 M (+16.81 %) |
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 718,396 | 0 | 1,856,606 | 1.1 M to 1.9 M (+63.12 %) |
| Mar 08 2016 | SNDX | Syndax Pharmaceuti ... | EVNIN LUKE | Director | Buy | C | 0.00 | 1,138,210 | 0 | 1,138,210 | 0 to 1.1 M |
Page: 1